Open AccessJournal Article
Regulation of lymphocyte responses by human gangliosides. I. Characteristics of inhibitory effects and the induction of impaired activation.
R L Whisler,A J Yates +1 more
Reads0
Chats0
TLDR
Concentrations of human gangliosides equivalent to the levels occurring in the sera of patients with certain malignancies are capable of actively inhibiting lymphocyte stimulation in addition to inducing impaired lymphocyte responses.Abstract:
Gangliosides obtained from normal human brain were found to inhibit the in vitro activation of human lymphocytes by nonspecific mitogens and allogeneic cells at concentrations between 3 to 50 microgram/1.5 to 1.7 X 10(5) lymphocytes/0.2 ml culture. Ganglioside inhibition did not represent cytotoxic effects or altered lectin binding and was independent of the mitogen concentration. In addition to concentration, the degree of inhibition was dependent on the mode of presentation to lymphocytes, since gangliosides incorporated within liposomal membranes displayed a synergistic inhibitory effect greater than predicted from the cultures receiving either gangliosides or liposomes alone. In binding experiments, radiolabeled ganglioside GM1 became associated with human lymphocytes within 10 min. However, approximately 72 hr pre-exposure of human lymphocytes to gangliosides was required to induce impaired lymphocyte responses to mitogens and allogeneic cells. Thus, concentrations of human gangliosides equivalent to the levels occurring in the sera of patients with certain malignancies are capable of actively inhibiting lymphocyte stimulation in addition to inducing impaired lymphocyte responses.read more
Citations
More filters
Journal ArticleDOI
Immune defects observed in patients with primary malignant brain tumors.
TL;DR: A model involving systemic cytokine dysregulation is presented to suggest how the immune defects arise in patients harboring gliomas and the glioma-derived factors which mediate this immunosuppression.
Journal Article
Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides.
TL;DR: The hypothesis that shedding of gangliosides may serve to protect tumor cells from host immune destruction is supported, as significant inhibition of normal lymphoproliferative responses by tumor-derived Ganglioside concentrations occurred at gangliosiside concentrations which are actually present in the fluid surrounding the tumor cells in vivo.
Book ChapterDOI
Cell surface glycolipids and glycoproteins in malignant transformation.
TL;DR: Several lines of evidence suggest that glycosphingolipids (GSLs) are involved in growth control, and cell transformation always results in a variety of alterations in different classes of GSL, which results in transformation-associated changes in membrane GSL.
Journal Article
Tumor gangliosides inhibit the tumor-specific immune response.
TL;DR: The clear conclusion that tumor-derived gangliosides inhibit syngeneic antitumor immune responses implicates these molecules as a potent factor in promoting tumor formation and progression.
Journal ArticleDOI
Immunotherapeutic Approaches for Glioma
Hideho Okada,Gary Kohanbash,Xinmei Zhu,Edward R. Kastenhuber,Aki Hoji,Ryo Ueda,Mitsugu Fujita +6 more
TL;DR: This review of recent advances in the CNS and CNS tumor immunology addresses factors that may promote immune escape of gliomas and discusses novel immunotherapy strategies that have been recently tested in non-CNS tumors and show great potential for application to glioma.